No increased CV risk with systemic psoriasis therapies?

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2011年 / 1367卷 / 1期
关键词：
Psoriasis; Infliximab; Etanercept; Adalimumab; Plaque Psoriasis;
D O I：
10.2165/00128415-201113670-00006
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：3 / 3
相关论文
共 50 条
  • [21] The Effect of Systemic Therapies on Langerhans' Cell Migration in Psoriasis
    Mellody, K.
    Shaw, F.
    Ogden, S.
    Dearman, R. J.
    Kimber, I.
    Griffiths, C. E.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2012, 132 : S51 - S51
  • [22] Current systemic therapies for psoriasis: Where are we now?
    Yamauchi, PS
    Rizk, D
    Kormeili, T
    Patnaik, R
    Lowe, NJ
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2003, 49 (02) : S66 - S77
  • [23] Economic evaluation of systemic therapies for moderate to severe psoriasis
    Sizto, S.
    Bansback, N.
    Feldman, S. R.
    Willian, M. K.
    Anis, A. H.
    BRITISH JOURNAL OF DERMATOLOGY, 2009, 160 (06) : 1264 - 1272
  • [24] Apremilast in combination with systemic and biologic therapies for psoriasis treatment
    Ighani, Arvin
    Georgakopoulos, Jorge R.
    Walsh, Scott
    Shear, Neil H.
    Yeung, Jensen
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2018, 79 (03) : AB46 - AB46
  • [25] Pharmacovigilance of systemic Psoriasis Therapies: Results from the German Psoriasis Registry PsoBest
    Sorbe, C.
    Kuehl, L. K.
    Rustenbach, S. J.
    von Kiedrowski, R.
    Radtke, M. A.
    Augustin, M.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2019, 17 : 196 - 197
  • [26] Increased CV risk with rosiglitazone but not pioglitazone
    Reactions Weekly, 2009, 1276 (1) : 2 - 2
  • [27] Celecoxib: no increased risk of CV events
    Reactions Weekly, 2002, 892 (1) : 4 - 4
  • [28] Psoriasis and Atherosclerotic CV Disease-Risk Factor or Risk Marker?
    Garshick, Michael S.
    Weber, Brittany N.
    Gelfand, Joel M.
    JAMA CARDIOLOGY, 2024, 9 (11) : 961 - 963
  • [29] Association between different systemic therapies and the risk of tuberculosis in psoriasis patients: A population-based study
    Ting, Sze-Wen
    Ting, Sze-Ya
    Lin, Yu-Sheng
    Lin, Ming-Shyan
    Kuo, George
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2021, 75 (12)
  • [30] Combination Use of Systemic Therapies in Psoriasis: Baseline Characteristics from the Corrona Psoriasis Registry
    Bonomo, Lauren
    Abittan, Brian J.
    Hashim, Peter W.
    Karki, Chitra
    Mason, Marc
    Lebwohl, Mark
    JOURNAL OF DRUGS IN DERMATOLOGY, 2019, 18 (08) : 731 - 740
12345